Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FCYSG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,439
Award facts
- Contract value 100% obligated
- $18,438.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,438.79 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant position as a critical federal medical procurement vendor, particularly supporting the Defense Health Agency and military healthcare systems. The company's SPE2DX prime contract enables the supply of diverse pharmaceutical products and medical commodities across multiple therapeutic domains to support federal healthcare operations worldwide. This specific delivery order for Otezla, a dermatological and rheumatological medication, exemplifies the company's role in fulfilling routine pharmaceutical procurement needs through the DLA's Medical Supply Chain. The competitively awarded nature of this and other orders under the contract demonstrates AmerisourceBergen's capability to meet federal requirements while competing in the open marketplace.
Quick answers
Who was awarded contract SPE2DB25FCYSG?
SPE2DB25FCYSG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FCYSG worth?
The government has obligated $18,439 on SPE2DB25FCYSG.
Is contract SPE2DB25FCYSG an order under another contract?
Yes. SPE2DB25FCYSG is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCYSG competed?
The extent of competition for SPE2DB25FCYSG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award